Hints and tips:
...Nancy Jecker, professor of bioethics at the University of Washington School of Medicine in Seattle, said that while Pfizer’s plan was welcome news, it should not be left to for-profit companies to set policy...
...The new rules give the federal government the power to negotiate lower prices for some of the most expensive prescription drugs produced by Pfizer, Merck and other pharma companies purchased by Medicare,...
...The oncology-focused biotech agreed a $43bn deal to be acquired by Pfizer....
...Illumina’s market capitalisation is roughly $33bn, about a quarter of Amgen’s and well below Pfizer’s $246bn valuation....
...The Moderna shot is authorised for anyone aged 18 and over, while the BioNTech/Pfizer vaccine can be given to anyone aged 12 or older....
...Asset managers in general lag the national leaders, which include Amazon, Meta and Pfizer, according to the Open Secrets website....
...Early use of [Pfizer’s drug] Paxlovid in this case provides additional protection against severe disease.”...
...Pfizer didn’t fall as much because of its wider array of products....
...Pfizer has said its pill cuts the risk of hospitalisation or death in Covid-19 patients by 89 per cent....
...On Tuesday The Washington Post reported the US government would announce a deal to buy 10m courses of Pfizer’s antiviral pill this week....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...Additional reporting by Kiran Stacey in Washington...
...Kathrin Jansen, Pfizer’s head of vaccine research and development, welcomed the positive recommendation by the committee....
...Additional reporting by Kiran Stacey in Washington, Oliver Barnes and Sarah Neville in London, Erika Solomon in Berlin, Nikou Asgari in New York, Mehul Srivastava in Jerusalem, and Sam Fleming in Brussels...
...But the US biotech, which began shipping its vaccine to Europe and Asia in January following months of long delays because of regulatory challenges, has called on Washington to do more to promote its vaccine...
...The FDA has already signed off on booster doses of messenger RNA vaccines made by Pfizer and Moderna for people with weak immune systems....
...The BioNTech/Pfizer jab for the youngest children is less potent than the others....
...However, antiviral drugs developed by Pfizer and Merck are beginning to be provided by health clinics following their recent authorisation by the FDA....
...The vote is a setback for Pfizer and Moderna....
...Joe Biden has urged rich countries to donate more Covid-19 vaccines to poorer parts of the world, as he announced the US will buy another 500m doses of BioNTech/Pfizer’s vaccine to give away....
...The BioNTech/Pfizer jab will be dispensed in “kid-sized” doses, a third of the size of those for people aged 12 years and more....
...Third doses will be available six months after full vaccination only for people who initially received BioNTech/Pfizer jabs....
...“Importantly, as part of the agreement, Pfizer will provide the US with 65m paediatric doses should Pfizer’s vaccine be approved for kids under 12, including doses available immediately upon authorisation...
...The decision comes a month after the FDA did the same for the BioNTech/Pfizer vaccine.The regulator added that people will be allowed to receive any of the three authorised shots, regardless of which they...
International Edition